DE3788847D1 - Hybrid-Promotor, expressionskontrollierende DNS-Sequenz und Expressions-Vektor. - Google Patents

Hybrid-Promotor, expressionskontrollierende DNS-Sequenz und Expressions-Vektor.

Info

Publication number
DE3788847D1
DE3788847D1 DE87402542T DE3788847T DE3788847D1 DE 3788847 D1 DE3788847 D1 DE 3788847D1 DE 87402542 T DE87402542 T DE 87402542T DE 3788847 T DE3788847 T DE 3788847T DE 3788847 D1 DE3788847 D1 DE 3788847D1
Authority
DE
Germany
Prior art keywords
expression
dna sequence
hybrid promoter
expression vector
controlling dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE87402542T
Other languages
English (en)
Other versions
DE3788847T2 (de
Inventor
Tatsurou Shibui
Michiru Kamizono
Yutaka Teranishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Kasei Corp
Original Assignee
Mitsubishi Kasei Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Kasei Corp filed Critical Mitsubishi Kasei Corp
Publication of DE3788847D1 publication Critical patent/DE3788847D1/de
Application granted granted Critical
Publication of DE3788847T2 publication Critical patent/DE3788847T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
DE19873788847 1986-11-11 1987-11-10 Hybrid-Promotor, expressionskontrollierende DNS-Sequenz und Expressions-Vektor. Expired - Fee Related DE3788847T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61268362A JPS63123383A (ja) 1986-11-11 1986-11-11 ハイブリツドプロモ−タ−、発現調節ｄｎａ配列および発現ベクタ−

Publications (2)

Publication Number Publication Date
DE3788847D1 true DE3788847D1 (de) 1994-03-03
DE3788847T2 DE3788847T2 (de) 1994-05-05

Family

ID=17457465

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19873788847 Expired - Fee Related DE3788847T2 (de) 1986-11-11 1987-11-10 Hybrid-Promotor, expressionskontrollierende DNS-Sequenz und Expressions-Vektor.

Country Status (4)

Country Link
EP (1) EP0267851B1 (de)
JP (1) JPS63123383A (de)
CA (1) CA1309042C (de)
DE (1) DE3788847T2 (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE914102A1 (en) 1990-11-26 1992-06-03 Genetics Inst Expression of pace in host cells and methods of use thereof
US5629167A (en) 1994-04-19 1997-05-13 Biocine S.P.A. Detection of antibodies against Chlamydia trachomatis pgp3 antigen in patient sera by enzyme-linked immunosorbent assay
US6444202B1 (en) 1996-11-25 2002-09-03 Bundesrepublic Deutschland, Vertreten Durch Den Bundesminister Fur Gesundheit Processed polypeptides with IL-16 activity, processes for their production and their use
CN1263854C (zh) 1997-11-06 2006-07-12 启龙股份公司 奈瑟球菌抗原
WO1999036544A2 (en) 1998-01-14 1999-07-22 Chiron S.P.A. Neisseria meningitidis antigens
GB9808932D0 (en) 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
EP1645631B1 (de) 1998-05-01 2007-10-24 Novartis Vaccines and Diagnostics, Inc. Neisseria Meningitidis Antigene und Zusammenstellungen
WO2000066741A2 (en) 1999-04-30 2000-11-09 Chiron S.P.A. Conserved neisserial antigens
GB9911683D0 (en) 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
GB9916529D0 (en) 1999-07-14 1999-09-15 Chiron Spa Antigenic peptides
PT2275551E (pt) 1999-10-29 2015-06-29 Novartis Vaccines & Diagnostic Péptidos antigénicos de neisseria
MXPA02006962A (es) 2000-01-17 2002-12-13 Chiron Spa Vacuna de vesicula de membrana exterior que comprende proteinas de membrana exterior de neisseria meningitidis serogrupo b.
US20020150979A1 (en) * 2000-10-04 2002-10-17 Naokazu Naitou Process for producing a protein
CA2881568C (en) 2000-10-27 2019-09-24 Novartis Vaccines And Diagnostics, Inc. Nucleic acids and proteins from streptococcus groups a & b
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
GB0107658D0 (en) 2001-03-27 2001-05-16 Chiron Spa Streptococcus pneumoniae
JP4592284B2 (ja) 2001-07-27 2010-12-01 カイロン ソチエタ ア レスポンサビリタ リミタータ 髄膜炎菌付着因子
EP2335724A1 (de) 2001-12-12 2011-06-22 Novartis Vaccines and Diagnostics S.r.l. Immunisierung gegen Chlamydia trachomatis
CA2485703A1 (en) 2002-05-24 2003-12-04 Fred W. Wagner Method for enzymatic production of glp-2(1-33) and glp-2-(1-34) peptides
EP1513945A4 (de) 2002-05-24 2008-12-24 Restoragen Inc Verfahren zur universellen enzymatischen herstellung bioaktiver peptide
WO2004046177A2 (en) 2002-11-15 2004-06-03 Chiron Srl Unexpected surface proteins in neisseria meningitidis
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
GB0308198D0 (en) 2003-04-09 2003-05-14 Chiron Srl ADP-ribosylating bacterial toxin
EP2392581A3 (de) 2003-04-25 2012-03-07 North Carolina State University Nukleinsäurensequenzen, die für Proteine an der Zelloberfläche von Lactobacillus acidophilus kodieren und deren Verwendung
ATE504645T1 (de) 2003-06-23 2011-04-15 Univ North Carolina State Für fructooligosaccharid-nutzende verbindungen codierende nukleinsäuren aus lactobacillus acidophilus und verwendungen davon
ATE541932T1 (de) 2003-11-21 2012-02-15 Nps Pharma Inc Herstellung von glucagonähnlichem peptid 2 und analogen
GB2429207A (en) 2004-02-02 2007-02-21 Ambrx Inc Modified human interferon polypeptides and their uses
US7459289B2 (en) 2004-03-08 2008-12-02 North Carolina State University Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor
JP2008503217A (ja) 2004-06-18 2008-02-07 アンブレツクス・インコーポレイテツド 新規抗原結合ポリペプチド及びそれらの使用
BRPI0519430A2 (pt) 2004-12-22 2009-02-10 Ambrx Inc hormânio do crescimento humano modificado
MX2007012755A (es) 2005-04-15 2008-01-14 Univ North Carolina State Metodos y composiciones para modular la adhesion y tolerancia al estres en bacterias.
WO2007059312A2 (en) 2005-11-16 2007-05-24 Ambrx, Inc. Methods and compositions comprising non-natural amino acids
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
EP2035035A2 (de) 2006-06-09 2009-03-18 Novartis AG Immunogene zusammensetzungen für streptococcus agalactiae
EP2615108B1 (de) 2006-09-08 2016-10-26 Ambrx, Inc. Modifiziertes humanes Plasmapolypeptid oder Fc-Gerüste und deren Verwendungen
KR20160121601A (ko) 2007-03-30 2016-10-19 암브룩스, 인코포레이티드 변형된 ｆｇｆ-21 폴리펩티드 및 그 용도
US8946148B2 (en) 2007-11-20 2015-02-03 Ambrx, Inc. Modified insulin polypeptides and their uses
NZ586947A (en) 2008-02-08 2012-11-30 Ambrx Inc Modified leptin polypeptides and their uses
AU2009215364B2 (en) 2008-02-21 2014-09-18 Glaxosmithkline Biologicals S.A. Meningococcal fHBP polypeptides
US10138283B2 (en) 2008-07-23 2018-11-27 Ambrx, Inc. Modified bovine G-CSF polypeptides and their uses
EA201170493A1 (ru) 2008-09-26 2011-10-31 Амбркс, Инк. Микроорганизмы и вакцины, зависимые от репликации неприродных аминокислот
NZ601659A (en) 2008-09-26 2014-02-28 Ambrx Inc Modified animal erythropoietin polypeptides and their uses
BR112012004275A2 (pt) 2009-08-27 2016-11-16 Novartis Ag polipeptídios híbridos incluindo sequências meningocócicas de fhbp
MX2012004850A (es) 2009-10-27 2012-05-22 Novartis Ag Polipeptidos fhbp meningococicos modificados.
WO2011087810A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
MX349301B (es) 2009-12-21 2017-07-21 Ambrx Inc Polipéptidos de somatotropina bovina modificados y sus usos.
US9040302B2 (en) 2010-05-19 2015-05-26 North Carolina State University Genetically modified Streptococcus thermophilus bacterium
RS65223B1 (sr) 2010-08-17 2024-03-29 Ambrx Inc Modifikovani polipeptidi relaksina i njihova primena
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
TWI480288B (zh) 2010-09-23 2015-04-11 Lilly Co Eli 牛顆粒細胞群落刺激因子及其變體之調配物
EP3060656A1 (de) 2013-10-24 2016-08-31 Yeda Research and Development Co., Ltd. Polynukleotide zur codierung von brex-system-polypeptiden und verfahren zur verwendung davon
CA2965502A1 (en) 2014-10-24 2016-04-28 Bristol-Myers Squibb Company Modified fgf-21 polypeptides and uses thereof
US10590426B2 (en) 2016-08-22 2020-03-17 Board Of Trustees Of Michigan State University Genetic control of cell size
IL250479A0 (en) 2017-02-06 2017-03-30 Sorek Rotem Genetically engineered cells expressing a disarm system that confers resistance to phages and methods for their production
TW201837051A (zh) 2017-02-08 2018-10-16 美商必治妥美雅史谷比公司 包含藥物動力學增強劑之經修飾之鬆弛素(relaxin)多肽及其用途
IL258467A (en) 2018-03-29 2018-07-04 Ilana Kolodkin Gal Methods of disrupting a biofilm and/or preventing formation of same
JP7441826B2 (ja) 2018-09-11 2024-03-01 アンブルックス，インコーポレイテッド インターロイキン－２ポリペプチド抱合物およびその使用
WO2020202142A2 (en) 2019-03-31 2020-10-08 Yeda Research And Development Co. Ltd. Anti-viral and anti-tumoral compounds
KR20220151202A (ko) 2020-03-11 2022-11-14 암브룩스, 인코포레이티드 인터류킨-2 폴리펩타이드 접합체 및 그의 사용 방법
IL288680A (en) 2021-12-05 2023-07-01 Yeda Res & Dev Genetically modified phages and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE237675C (de) *
US4495280A (en) * 1981-05-20 1985-01-22 The Board Of Trustees Of The Leland Stanford Jr. University Cloned high signal strength promoters
DD237675A1 (de) * 1981-07-27 1986-07-23 Liebscher Verfahren zur herstellung eines expressionsvektors
US4689406A (en) * 1983-08-10 1987-08-25 Amgen Enhancement of microbial expression of polypeptides
JPS60221091A (ja) * 1983-12-21 1985-11-05 Kyowa Hakko Kogyo Co Ltd 新規プロモ−タ−
GB8431818D0 (en) * 1984-12-17 1985-01-30 Bujard H Expression control sequence

Also Published As

Publication number Publication date
EP0267851A2 (de) 1988-05-18
EP0267851B1 (de) 1994-01-19
JPS63123383A (ja) 1988-05-27
CA1309042C (en) 1992-10-20
EP0267851A3 (en) 1989-07-26
DE3788847T2 (de) 1994-05-05

Similar Documents

Publication Publication Date Title
DE3788847T2 (de) Hybrid-Promotor, expressionskontrollierende DNS-Sequenz und Expressions-Vektor.
DE3670197D1 (de) Frisierstab.
DE3888381D1 (de) Hefevektor.
DE3783802T2 (de) Lauffläche von Luftreifen.
NO166779C (no) Passasjerbro.
FI870192A0 (fi) Nya tieno-1,4-diazepiner.
DE3876155T3 (de) Dehydrierungskatalysator.
DE3782060T2 (de) Flaschentraegeranordnung.
FI874690A (fi) Rumsenhet, i synnerhet kabin eller hytt pao fartyg.
DE3885543D1 (de) Dehydrierungskatalysator.
NO872174D0 (no) Polypetidpreparater med oekt biologisk tilgjengelighet.
FI884361A (fi) Foertjockad, vattenhaltig tvaettblandning innehaollande litet eller inget fosfat.
FI872044A0 (fi) Infaestningsanordning, foeretraedesvis foer doerrar, foenster eller dylikt.
DE3783176D1 (de) Bis-dioxopiperazin-abkoemmlinge.
DE3769544D1 (de) Radzierblende.
DE3787630D1 (de) Flugaschebehandlung.
FI851950L (fi) Saekerhetsbehaollare, saerskilt pengskrin eller kassaskaop.
DE3769589D1 (de) Segelanordnung.
FI885030A (fi) Anordning foer foerminskning eller malning av fiberaemnesmaterial, saerskilt en trumraffinoer.
FI872465A (fi) Vektorer, vilka innehaoller vaermechockreglerande dna-sekvenser.
FI880952A0 (fi) Vaegg eller vaeggelement foer saekerhetsanordningar, saosom kassavalv, saekerhetsdoerrar, kassaskaop eller dylika.
NO872386L (no) Peptider.
FI872681A (fi) Kemiskt sjaelvkopierande eller ensamkopierande papper.
FI862337A0 (fi) Spaenningsanordning foer en pappersmaskins vaevnader saosom viror, filtar, torkningsvaevnader, speciellt filtarna i presspartiet.
FI873253A0 (fi) Acylbaerarprotein-dna-sekvens och -syntes.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee